🍬 Type 1 Diabetes Mellitus (T1DM)
| Type | Description |
|---|---|
| Type 1A (autoimmune) | Positive for autoantibodies (e.g., anti-GAD, IA2) |
| Type 1B (idiopathic) | No detectable autoantibodies |
| Latent Autoimmune Diabetes in Adults (LADA) | Milder, slower-onset autoimmune diabetes in adults |
| System | Complications |
|---|---|
| Metabolic | Diabetic ketoacidosis (DKA), hypoglycemia |
| Renal | Microalbuminuria → diabetic nephropathy |
| Ophthalmologic | Retinopathy, cataracts |
| Neurologic | Peripheral neuropathy, autonomic dysfunction |
| Cardiovascular | Early atherosclerosis, hypertension |
| Psychosocial | Eating disorders, anxiety, school difficulties |
| Test | Reason |
|---|---|
| Blood glucose (random) | ≥11.1 mmol/L with symptoms confirms diagnosis |
| Fasting glucose | ≥7.0 mmol/L |
| HbA1c | ≥6.5% (48 mmol/mol) |
| Urine ketones/glucose | Suggests ketosis and glycosuria |
| Blood gas, serum ketones | For DKA assessment |
| Test | Reason |
|---|---|
| Autoantibodies (anti-GAD, IA2, ZnT8) | Confirm autoimmune type |
| C-peptide | Reflects endogenous insulin production |
| Thyroid function tests | Screen for autoimmune thyroiditis |
| TTG-IgA | Screen for celiac disease |
| Lipid profile | Baseline cardiovascular risk |
| Treatment | Complication | Monitoring | Expected Results |
|---|---|---|---|
| Insulin therapy | Hypoglycemia, lipodystrophy, weight gain | SMBG/CGM, injection site rotation, BMI | Stable glucose, HbA1c <7.5%, minimal hypo |
| Poor compliance | DKA, hyperglycemia, long-term complications | HbA1c every 3 months, ketone testing | HbA1c <7.5%, no DKA episodes |
| Domain | Frequency | What to Monitor |
|---|---|---|
| HbA1c | Every 3 months | Target <7.5% |
| Growth & puberty | Every 3–6 months | Height, weight, Tanner staging |
| Renal | Yearly from age 10 or 5 years after diagnosis | Urine albumin:creatinine ratio |
| Eyes | Yearly from age 12 | Retinal exam (retinopathy screening) |
| Thyroid function | Yearly | TSH, free T4 |
| Celiac screening | Every 1–2 years | TTG-IgA, total IgA |
| Lipids | At puberty, then every 5 years | Fasting lipid profile |
| Mental health | As needed | Mood, anxiety, eating disorder screening |
| Support Group | Description | Contact/Link |
|---|---|---|
| Diabetes Malaysia | Advocacy, awareness, peer support | www.diabetes.org.my |
| MySihat (Health Promotion Board) | Educational materials and family resources | www.mysihat.gov.my |
| Hospital-based diabetes clinics | Dietitian, endocrinologist, diabetic educator | Available at HKL, HUSM, UMMC, Penang GH, etc. |
| Facebook groups (e.g. T1DM Malaysia) | Parent and adolescent peer-to-peer support | Search “Type 1 Diabetes Malaysia” on Facebook |